CDXS, Codexis, Inc.
** CDXS reported that it has signed an Exclusive Negotiation Agreement with Shell.
Under this agreement, Shell has agreed to negotiate exclusively with CDXS through September 1, 2012 the terms of a new agreement under which Shell would grant to CDXS certain rights and licenses in the biofuels field to develop and sell cellulase enzymes to third parties on a worldwide basis, except Brazil.
CDXS has exclusive rights to commercialize its cellulase enzyme technology in all other fields.
CDXS is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates.
More about CDXS at www.codexis.com.
JOEZ, Joe's Jeans Inc.
** For the second quarter of fiscal 2012, JOEZ posted overall net sales of $28.6 million. a 16% increase year over year, and overall gross profit of $13.6 million, an 18% increase compared to the same period the prior year.
JOEZ designs, produces and sells apparel and apparel-related products to the retail and premium markets under the Joe's(R) brand and related trademarks.
More about JOEZ at www.joesjeans.com.
GY, GenCorp Inc.
** Aerojet, a GY company, reported that it was one of a number of firms selected to develop engineering demonstrations and risk reduction concepts for NASA's Space Launch System (SLS).
Aerojet's "Full-Scale Combustion Stability Demonstration" solution was geared at improving the affordability, reliability and performance of an advanced booster for SLS.
This selection is expected to result in a firm-fixed price contract with a period of performance beginning on or about Oct. 1, 2012 and ending on March 31, 2015.
GY's Aerojet is a world-recognized aerospace and defense leader principally serving the missile and space propulsion, defense and armaments markets.
GY is a leading technology-based manufacturer of aerospace and defense products and systems with a real estate segment that includes activities related to the entitlement, sale, and leasing of the company's excess real estate assets.
More about GY at www.gencorp.com.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE) advertises for a particular client, Crown Equity Holdings Inc. (CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE), if paid in stock, can and may sell those securities during the advertising period.